SR2508 (etanidazole) pharmacokinetics and biochemical effects in tumor and normal tissues of scid mice bearing HT-29 human colon adenocarcinoma
- 5 October 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (7) , 1251-1256
- https://doi.org/10.1016/0006-2952(93)90475-c
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridinePublished by Elsevier ,2004
- Inhibition of glutathione peroxidase and glutathione transferase in mouse liver by misonidazoleBiochemical Pharmacology, 1986
- Identification of a reactive glutathione conjugate as a metabolite of SR-2508 in CHO cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Sensitization of cancer chemotherapeutic agents by nitroheterocyclicsBiochemical Pharmacology, 1986
- Biochemistry of reduction of nitro heterocyclesBiochemical Pharmacology, 1986
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- A severe combined immunodeficiency mutation in the mouseNature, 1983
- Enhancement of Misonidazole Radiosensitization by an Inhibitor of Glutathione BiosynthesisInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1983
- [51] Assays for differentiation of glutathione S-TransferasesPublished by Elsevier ,1981
- Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1978